| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Gerardo Hernandez is Chief Financial Officer at TMDX. Gerardo Hernandez's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.2M at current prices.
Our model assigns Gerardo Hernandez a middling insider score of 51/100, based on 3 past trades. On a 3-month view, 66.7% of the rated trades came out ahead, averaging +33.7% over three months.
The TMDX filings lean toward selling, a net 8,531 shares.
Gerardo Hernandez has 5 Form 4 filings on record from December 2024 to July 2026, all as Chief Financial Officer at TransMedics Group (TMDX), 2024–2026.
The 12 reported transactions were 4 open-market sales, 3 stock awards, 3 option or other derivative awards and 2 option exercises.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.2M.
The largest open-market sale was 7,611 shares of TMDX at an average $146.81 on March 4, 2026, about $1.1M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.